RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW24D2ED0C26E6D9FE

https://w3id.org/ripe/ripe-kg/work/RIPEW24D2ED0C26E6D9FE
SubjectPredicateObject
ripekg:work/10.1016%2Fj.pnpbp.2018.02.007The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial http://purl.org/spar/cito/cites ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial dcterms:title Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type node1
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type rdfs:Resource
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type owl:Thing
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type prov:Entity
ripekg:work/RIPEW24D2ED0C26E6D9FEClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial rdf:type ripe:WorkWork